A Phase II/III of Hepenofovir Fumarate Tablets (HTS) for Chronic Hepatitis B
Clinical trial NCT07203118 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07203118
- Sponsor
- Xi'an Xintong Pharmaceutical Research Co.,Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2027-06-30
- Enrollment
- 1444
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.